ULTIPAQ FSR100308-20Recalls & reported problems
Medos International Sàrl · ULTIPAQ microcoil ULTIPAQ 10 Stretch Resistant Coil 3mm x 8cm 190cm Contents: 1 Detachable Coil System · Class 2 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00878528001638), received between Jul 19, 2017 and Sep 16, 2021 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Device Damaged by Another Device” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Device Damaged by Another Device1
- Difficult to Advance1
- Material Separation1
- Material Split, Cut or Torn1
- Migration or Expulsion of Device1
- Stretched1
Patient problems
- Neurological Deficit/Dysfunction1
- No Clinical Signs, Symptoms or Conditions1
- Stroke/CVA1
- Thrombosis1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 16, 2021Difficult to Advance; Material Split, Cut or Torn; Difficult to Advance; Material Split, Cut or Torn
AS REPORTED BY THE FIELD, DURING A COIL EMBOLIZATION OF THE LEFT MIDDLE CEREBRAL ARTERY (MCA), RESISTANCE WAS ENCOUNTERED WHEN TRYING TO INTRODUCE THE ULTIPAQ 10 SR, 3MMX8CM COIL ((B)(4)) INTO THE UNSPECIFIED MICROCATHETER (MC). THE USER REPORTED THAT THE RESISTANCE WAS FELT AT THE MC/RHV/INTRODUCER SHEATH JUNCTION WHEN TRYING TO TRANSFER THE COIL FROM INTRODUCER SHEATH TO MC. THE DEVICE NEVER ENTERED THE MC. SHE ALSO REPORTS A BREACH IN THE SHEATH UPON REMOVAL AND INSPECTION. THIS WAS NOTICED BEFORE COIL ENTERED INTO THE MC. THERE WAS NO EFFECT TO THE CASE OR PATIENT¿S OUTCOME. ADDITIONAL INFORMATION RECEIVED INDICATED THAT IT WAS NOT NECESSARY TO REMOVE THE MICROCATHETER. A CONTINUOUS FLUSH WAS MAINTAINED. THE INTRODUCER WAS FLUSHED UNTIL LIQUID WAS VISIBLE AT THE DISTAL END OF THE SLIT IN THE CLEAR TUBE. THE TIP OF THE INTRODUCER WAS FIRMLY INSTALLED INTO THE HUB OF THE MICROCATHETER AND LOCKED WITH THE RHV DURING DEVICE ADVANCEMENT. NO EXCESSIVE FORCE WAS APPLIED TO THE DEVICE. BASED ON THE PRODUCT ANALYSIS OF THE DEVICE RECEIVED, THE EMBOLIC COIL WAS FOUND STRETCHED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12482024 ↗InjuryJul 19, 2017Migration or Expulsion of Device; Material Separation; Stretched; Device Damaged by Another Device; Migration or Expulsion of Device; Material Separation; Stretched; Device Damaged by Another Device
AS REPORTED BY A PHYSICIAN, DURING COIL EMBOLIZATION OF A 5MM (NECK 3MM) ANTERIOR COMMUNICATING ARTERY ANEURYSM, AFTER SUCCESSFUL DEPLOYMENT OF THE FIRST COIL, A 4MM X 15CM MICRUSPHERE (SPH10040020/C31600), AN ULTIPAQ 3MM X 8CM (CATALOG FSR10030820/C27386) MILDLY BULGED INTO THE PARENT ARTERY. IT WAS DECIDED TO WITHDRAW THE COIL; HOWEVER, WHILE TAKING IT OUT, THE COIL WAS ENTANGLED WITH THE PREVIOUS COIL, STRETCHED AND SEPARATED WITH THE PROXIMAL END SEEN IN THE THORACIC AORTA AND THE DISTAL END IN THE ANEURYSMAL CAVITY, RESULTING IN REDUCTION OF BLOOD FLOW THROUGH THE ARTERY. WHILE TAKING OUT THE EXCELSIOR SL 10 (1.7F DISTAL END) MICROCATHETER WITH THE COIL, THE WHOLE COIL MASS MOVED AND MIGRATED INTO THE PARENT ARTERY. THE ATTEMPT TO REPLACE THE COIL MASS USING A PUSHER WIRE AND MICROWIRE WERE INEFFECTIVE. THERE WAS PARTIAL REPOSITIONING BY BALLOON ANGIOPLASTY WITH A SCEPTER BALLOON; HOWEVER, THE COILS REMAINED IN THE PATIENT WITH THE PROXIMAL END OF THE ULTIPAQ FLOATING WITHIN THE THORACIC AORTA. WHEN THE PATIENT WAS EXTUBATED, SHE WAS NOT ABLE TO MOVE HER RIGHT ARM AND LEG. THE PATIENT WAS RE-CANNULATED AND FOUND TO HAVE THROMBOGENIC A1 OCCLUSION AND WAS POTENTIALLY MORE VULNE
Patient problems: Neurological Deficit/Dysfunction; Stroke/CVA; Thrombosis
MAUDE report 6724976 ↗
Other DEVICE, NEUROVASCULAR EMBOLIZATION devices
- POD RBYPODJ60-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION355 reports
- Penumbra System SCH1Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION295 reports
- RUBY Coil RBY4C0860-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION276 reports
- Smart Coil 400SMTHXSFT0208Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION165 reports
- Penumbra System RH1-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION154 reports
- Optima Coil System OPTI0208CSS10Balt USA LLC · Device, Neurovascular Embolization3 recalls3 reports
- POD RBYPOD6-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION148 reports
- POD RBYPODJ30-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION132 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page